Sponsored
by Merck
How the Vaccine Industry and Biotechs Can Accelerate Pandemic Responses
The global Covid-19 pandemic has forced us to put our lives on hold, and a…
12/01/2021 - 6 minutes
mRNA technology
EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its…
22/12/2020 - 5 minutes
Covid-19 Pandemic Drives RNA Therapeutics into the Mainstream
With messenger RNA being pushed to the market in record time and Alnylam’s historic approval…
02/12/2020 - 8 minutes
Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment
The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop…
02/04/2020 - 3 minutes
Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
The first vaccine against coronavirus disease could one day be made of mRNA. How is…
30/03/2020 - 7 minutes
CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute
The German biotech CureVac -- which is developing an mRNA vaccine against coronavirus -- has…
17/03/2020 - 2 minutes
EU Project Receives €15M to Bring mRNA Therapy to a Wider Audience
An EU research project has launched with the aim of bringing mRNA treatments to a…
08/11/2019 - 4 minutes
This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation
Based close to Berlin, Germany, the biotech startup Pantherna Therapeutics is developing a messenger RNA…
02/08/2019 - 4 minutes
BioNTech Raises Whopping €290M to Fund Personalized mRNA Vaccines for Cancer
In one of the biggest ever funding rounds in European biotech, the German company BioNTech…
09/07/2019 - 3 minutes
Rapid Response mRNA Vaccine Facility Gets €30M Funding
An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development…
01/03/2019 - 3 minutes
What Does the Largest Biotech IPO Ever Mean for European Biotech?
With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The…
11/12/2018 - 3 minutes
Pfizer Offers €374M for German mRNA Flu Vaccine
BioNTech, based in Mainz, Germany, has entered into a partnership with Pfizer worth up to…
16/08/2018 - 2 minutes
